1. INTRODUCTION
1.1. MARKET OVERVIEW
1.2. MARKET DEFINITION
1.3. SCOPE OF THE STUDY
1.4. MARKET SEGMENTATION
1.5. CURRENCY
1.6. ASSUMPTIONS
1.7. BASE AND FORECAST YEARS TIMELINE
1.8. KEY BENEFITS TO THE STAKEHOLDER
2. RESEARCH METHODOLOGY
2.1. RESEARCH DESIGN
2.2. RESEARCH PROCESSES
3. EXECUTIVE SUMMARY
3.1. KEY FINDINGS
3.2. CXO PERSPECTIVE
4. MARKET DYNAMICS
4.1. MARKET DRIVERS
4.2. MARKET RESTRAINTS
4.3. PORTER'S FIVE FORCES ANALYSIS
4.4. INDUSTRY VALUE CHAIN ANALYSIS
4.5. ANALYST VIEW
5. IV BAGS MARKET BY MATERIAL TYPE
5.1. INTRODUCTION
5.2. POLYVINYL CHLORIDE (PVC)
5.3. POLYETHYLENE (PE)
5.4. ETHYLENE VINYL ACETATE (EVA)
5.5. POLYPROPYLENE (PP)
5.6. COPOLYESTER ETHER
5.7. OTHERS
6. IV BAGS MARKET BY SIZE
6.1. INTRODUCTION
6.2. 250 ML TO 500 ML
6.3. LESS THAN 250 ML
6.4. 500 ML TO 1000 ML
6.5. MORE THAN 1000 ML
7. IV BAGS MARKET BY CHAMBER TYPE
7.1. INTRODUCTION
7.2. SINGLE CHAMBER
7.3. MULTIPLE CHAMBER
8. IV BAGS MARKET END-USER
8.1. INTRODUCTION
8.2. PARENTERAL NUTRITION
8.3. INTRAVENOUS THERAPIES
9. IV BAGS MARKET BY GEOGRAPHY
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. MAJOR PLAYERS AND STRATEGY ANALYSIS
10.2. MARKET SHARE ANALYSIS
10.3. MERGERS, ACQUISITIONS, AGREEMENTS, AND COLLABORATIONS
10.4. COMPETITIVE DASHBOARD
11. COMPANY PROFILES
11.1. AEROSUN HEALTHCARE
11.2. AMNEAL PHARMACEUTICALS
11.3. BAXTER INTERNATIONAL, INC.
11.4. B.BRAUN MEDICAL, INC.
11.5. FRESENIUS KABI
11.6. ICU MEDICAL, INC.
11.7. KRATON CORPORATION
11.8. MACOPHARMA SA
11.9. MEDICOPACK
11.10. MEDX HEALTHCARE PVT. LTD.
11.11. POLYCINE GMBH
11.12. RENOLIT
11.13. SIPPEX
著作権 ©2022 無断複写・転載を禁じます
